Stayble Therapeutics presented at Swedish Shareholders´ Association´s event Aktiedagen Stockholm 2022
Stayble Therapeutics' CEO Andreas Gerward gave a presentation on 14 March 2022 at Aktiedagen Stockholm 2022, an event arranged by Swedish Shareholders´ Association´s.CEO Andreas Gerward presented the Company, the development of the injection treatment STA363 for degenerative disc disease and gave a general update on the ongoing clinical phase 2b-trial. The presentation from March 14 is available at: https://youtu.be/yevDh5o0WgI